BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18647804)

  • 1. Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.
    Utz AL; Yamamoto A; Sluss P; Breu J; Miller KK
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4033-40. PubMed ID: 18647804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive insulin-like growth factor-I in obesity.
    Frystyk J; Brick DJ; Gerweck AV; Utz AL; Miller KK
    J Clin Endocrinol Metab; 2009 Aug; 94(8):3093-7. PubMed ID: 19470623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity.
    Brick DJ; Gerweck AV; Meenaghan E; Lawson EA; Misra M; Fazeli P; Johnson W; Klibanski A; Miller KK
    Eur J Endocrinol; 2010 Aug; 163(2):185-91. PubMed ID: 20501597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of growth hormone on bioactive IGF in overweight/obese women.
    Dichtel LE; Bjerre M; Schorr M; Bredella MA; Gerweck AV; Russell BM; Frystyk J; Miller KK
    Growth Horm IGF Res; 2018 Jun; 40():20-27. PubMed ID: 29679919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
    Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
    Lukanova A; Lundin E; Zeleniuch-Jacquotte A; Muti P; Mure A; Rinaldi S; Dossus L; Micheli A; Arslan A; Lenner P; Shore RE; Krogh V; Koenig KL; Riboli E; Berrino F; Hallmans G; Stattin P; Toniolo P; Kaaks R
    Eur J Endocrinol; 2004 Feb; 150(2):161-71. PubMed ID: 14763914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity.
    Stanley TL; Feldpausch MN; Murphy CA; Grinspoon SK; Makimura H
    Growth Horm IGF Res; 2014 Feb; 24(1):10-5. PubMed ID: 24291224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of bone microarchitecture and mechanical properties in obese men.
    Bredella MA; Lin E; Gerweck AV; Landa MG; Thomas BJ; Torriani M; Bouxsein ML; Miller KK
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4115-22. PubMed ID: 22933540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.
    Utz AL; Yamamoto A; Hemphill L; Miller KK
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2507-14. PubMed ID: 18445664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients.
    Maccario M; Ramunni J; Oleandri SE; Procopio M; Grottoli S; Rossetto R; Savio P; Aimaretti G; Camanni F; Ghigo E
    Int J Obes Relat Metab Disord; 1999 Jun; 23(6):612-8. PubMed ID: 10411234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
    Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
    Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.